From Bioblast
MitoGlobal first |
Mitochondria-Targeted Drug Development 2022 Boston US
Boston, MA US, 2022 Feb 22-24. 2nd Annual Mitochondria-Targeted Drug Development - Overcome the Challenge of Treating Unmet Medical Needs Caused by Mitochondrial Dysfunction |
Β» https://mitochondria-targets.com/
hansonwade (2022-02-22) MitoGlobal
Abstract: 2nd Annual Mitochondria-Targeted Drug Development, Boston MA, US, 2022.
General information
- The Digital Mitochondria-Targeted Drug Development is the only industry-led meeting focused on end-to-end mitochondria-targeting. Incorporating insights from leading academics and pioneering biotech, this forum will specifically focus on targeting mitochondrial dysfunction to develop therapies for chronic diseases caused by mitochondrial DNA mutation/nuclear DNA mutations, muscle dystrophy diseases/muscle loss, metabolic disorders, neurodegenerative disease, and conditions linked to oxidative damage.
- Join 80+ leading experts as they navigate common challenges and opportunities for treating unmet medical needs caused by mitochondrial dysfunction. Mitobridge/Astellas, Minovia Therapeutics, Abliva, GenSight Biologics, Stealth Biotherapeutics and many more will unite drive to better understand how to create effective and scalable mitochondrial therapies.
- Download the brochure here
Program
- The program is available here
Registration
- Register here
- Early bird & Team Discounts Available until Dezember, 17
Organizer
- Hanson Wade
- Mail: [email protected]
- https://hansonwade.com/
Speaker
- See the full list of speakers here
Health and Safety
- All attendees will be required to complete a health declaration prior to attending the event. As part of this, attendees must declare that they are either fully vaccinated and /or have completed a negative Lateral Flow Test or PCR Test within 48 hours of the event*.
For further information around Health and Safety onsite, please visit the FAQ page here.
- *Please note, this is subject to change at any time without prior notice.
Listed under MitoGlobal Events.
Labels:
2022, MitoGlobal